Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $34.1600 (2.34%) ($33.2400 - $34.7500) on Tue. May. 22, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.58% (three month average) | RSI | 58 | Latest Price | $34.1600(2.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.3% a day on average for past five trading days. | Weekly Trend | EDIT advances 3.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.79% in a week (0% probabilities). VXX(-13%) VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.79% (StdDev 3.58%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
5 Day Moving Average | $35.49(-3.75%) | 10 Day Moving Average | $35.31(-3.26%) | 20 Day Moving Average | $34.03(0.38%) | To recent high | -22.5% | To recent low | 8.8% | Market Cap | $2.121b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |